The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most ...

This experiment relies on MIT to explore the optimal operating conditions for embedded immobilized biological fillers under low temperatures, given the aforementioned characteristics of rural ...

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

Scientists have developed Evo 2, a powerful AI model that can analyze and generate DNA sequences across all domains of life.

At the heart of the Midsize platform is Atlas, Lucid’s all new electric drive unit. Atlas advances Lucid’s integrated ...

The path from 1G to 6G traces from dumb pipes to a nervous system ...

The startup is developing AI foundation models trained on DNA rather than text or code, applying deep learning techniques to ...

University of Edinburgh spin-out BIOCAPTIVA secures £1.58m funding and launches its msX liquid biopsy technology in the US to improve cancer diagnostics and research.